Elwood Capital Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.58M Sell
125,180
-100,000
-44% -$3.17M 1.77% 22
2026
Q1
$7.09M Sell
225,180
-50,139
-18% -$1.58M 3.6% 8
2025
Q4
$8.11M Buy
275,319
+15,000
+6% +$417K 4.83% 6
2025
Q3
$6.57M Buy
260,319
+140,000
+116% +$3.41M 4.01% 12
2025
Q2
$2.89M Sell
120,319
-21,005
-15% -$487K 2.22% 14
2025
Q1
$3.24M Buy
141,324
+13,824
+11% +$334K 2.8% 15
2024
Q4
$3.23M Buy
+127,500
New +$3.23M 3.17% 14

Other funds holding RTO

Elwood Capital Partners's RTO Position: Q2 2026 in Review

Elwood Capital Partners reduced its Rentokil (RTO) stake by 44% in Q2 2026, selling an estimated $3.17M and leaving 125,180 shares worth $3.58M. The position accounts for 1.77% of the portfolio, ranked #22.

Elwood Capital Partners first reported a position in RTO in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.11M in Q4 2025. 283 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Elwood Capital Partners held 125,180 shares of Rentokil worth $3.58M as of Q2 2026.
  • Elwood Capital Partners sold 100,000 Rentokil shares in Q2 2026, an estimated $3.17M.
  • Rentokil made up 1.77% of Elwood Capital Partners's portfolio in Q2 2026, its #22 holding.
  • Elwood Capital Partners first reported a position in Rentokil in Q4 2024 and has held it in 7 quarters since.
  • Elwood Capital Partners's Rentokil position peaked at $8.11M in Q4 2025.
  • 283 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Elwood Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.